Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults.
暂无分享,去创建一个
L. Fried | Jing Tian | Xiyan Xu | S. Leng | B. Resnick | N. Weng | J. Walston | Q. Xue | J. Bream | R. Hamilton | Huifen Li | S. Yeh | Xu Yao
[1] S. Leng,et al. Inflammation and immune system alterations in frailty. , 2011, Clinics in geriatric medicine.
[2] A. Falsey,et al. Clinical and immunologic predictors of influenza illness among vaccinated older adults. , 2010, Vaccine.
[3] M. Makary,et al. Frailty as a predictor of surgical outcomes in older patients. , 2010, Journal of the American College of Surgeons.
[4] F. Oftung,et al. Standardization and validation of assays determining cellular immune responses against influenza. , 2010, Vaccine.
[5] C. Macintyre,et al. Incompletely matched influenza vaccine still provides protection in frail elderly. , 2010, Vaccine.
[6] Tom Jefferson,et al. Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.
[7] K. Nichol. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. , 2009, Vaccine.
[8] Mark A. Miller,et al. Influenza vaccination and mortality benefits: new insights, new opportunities. , 2009, Vaccine.
[9] L. Ferrucci,et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[10] L. Fried,et al. Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: Results from the Women’s Health and Aging Studies I , 2009, Experimental Gerontology.
[11] C. Ewen,et al. Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. , 2009, Vaccine.
[12] L. Ferrucci,et al. Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14+ monocytes in frail older adults , 2009, Mechanisms of Ageing and Development.
[13] Edward Ehlinger,et al. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Nelson,et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study , 2008, The Lancet.
[15] G. Wang,et al. T‐Lymphocytes Expressing CC Chemokine Receptor‐5 Are Increased in Frail Older Adults , 2008, Journal of the American Geriatrics Society.
[16] M. Basileo,et al. Effects of Repeated Annual Influenza Vaccination on Antibody Responses against Unchanged Vaccine Antigens in Elderly Frail Institutionalized Volunteers , 2007, Gerontology.
[17] K. Nichol,et al. Effectiveness of influenza vaccine in the community-dwelling elderly. , 2007, The New England journal of medicine.
[18] Cecile Viboud,et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.
[19] C. Bridges,et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.
[20] L. Fried,et al. Inflammation and Frailty in Older Women , 2007, Journal of the American Geriatrics Society.
[21] C. Ewen,et al. T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1 , 2006, The Journal of Immunology.
[22] B. Psaty,et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. , 2006, International journal of epidemiology.
[23] K. Nichol,et al. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons. , 2006, Vaccine.
[24] Cécile Viboud,et al. Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.
[25] Luigi Ferrucci,et al. From bedside to bench: research agenda for frailty. , 2005, Science of aging knowledge environment : SAGE KE.
[26] R. Bleackley,et al. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. , 2005, Vaccine.
[27] J. Margolick,et al. T cell subsets and mortality in older community-dwelling women , 2005, Experimental Gerontology.
[28] Cecile Viboud,et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.
[29] P. Assantachai,et al. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[30] Keiji Fukuda,et al. Influenza-associated hospitalizations in the United States. , 2004, JAMA.
[31] S. Leng,et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty , 2004, Aging clinical and experimental research.
[32] L. Ferrucci,et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[33] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[34] L. Fried,et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. , 2002, Archives of internal medicine.
[35] Kathleen Koenig,et al. Serum Interleukin‐6 and Hemoglobin as Physiological Correlates in the Geriatric Syndrome of Frailty: A Pilot Study , 2002, Journal of the American Geriatrics Society.
[36] E. Gardner,et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly , 2002, Experimental Gerontology.
[37] D. Knook,et al. Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects * , 2001, Journal of medical virology.
[38] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[39] G. Dinant,et al. The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .
[40] S. Gravenstein,et al. Efficacy of an Influenza Hemagglutinin‐Diphtheria Toxoid Conjugate Vaccine in Elderly Nursing Home Subjects During an Influenza Outbreak , 1994, Journal of the American Geriatrics Society.
[41] W. Beyer,et al. Antibody induction by influenza vaccines in the elderly: a review of the literature. , 1989, Vaccine.
[42] R. Reichman,et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. , 1982, The New England journal of medicine.
[43] Bennett Nm. Diagnosis of influenza. , 1973 .
[44] N. Bennett. DIAGNOSIS OF INFLUENZA , 1973, The Medical journal of Australia.